Michelle Hall talks about her involvement with ACTA’s special interest group for network managers (SIGNet), and how the ACTA and CT:IQ Consumer Involvement and Engagement Toolkit played a crucial role in DACRIN’s own guidelines for involving consumers in research.
Latest Resource
-
Consumer engagement, equity and diversity working group
-
Teletrials web resource
-
How DACRIN is enhancing consumer involvement in research
-
ACTA Masterclass 5: Consumer Engagement
-
ACTA – ATP Webinar : Avoiding Groundhog Day
-
ACTA Masterclass series on the Development of a Clinical Trial Network #4: Industry Partnerships
-
CTN and CQR collaborations
-
ACTA Masterclass series on the Development of a Clinical Trial Network #2 – Governance
-
ACTA Masterclass series on the Development of a Clinical Trial Network #1 – Establishment of a CTN
-
ACTA Masterclass series on Development of a Clinical Trial Network #3 – Funding
-
Involve Australia Guidelines for Community Involvement in Genomic Research
-
Case study: ACTA’s crucial contribution to the growth of the Mental Health Australia General Clinical Trial Network (MAGNET)
-
Workshop: How to better develop cross-network collaborations and linkages
-
Exploring greater partnership between Clinical Trial Networks, Clinical Quality Registries and Trial Coordinating Centres with Industry – Environmental Scan
-
Recommendations to improve cultural and linguistic diversity in clinical trials
-
Development of the Consumer Involvement and Engagement Toolkit
-
Activities supporting the growth of Clinical Trial Networks in Australia
-
A pilot study to prospectively estimate the health and economic return on research investment
-
A snapshot of consumer engagement in clinical trials in Australia
-
Fundraising strategy: guidance for CTNs
-
Communications and marketing strategy: guidance for CTNs
-
HeSANDA initiative stakeholder consultation project – final report
-
Communications and Marketing for Clinical Trials Networks: Website content management systems (CMS)
-
Communications and Marketing for Clinical Trials Networks: Social Media
-
Communications and Marketing for Clinical Trials Networks: Email Marketing
-
Communications and Marketing for Clinical Trials Networks: Data Dashboards
-
HeSANDA initiative stakeholder consultation project – Executive Summary of key findings
-
HeSANDA Stakeholder Consultation Project
-
Business Review of CTNs
-
Risk Management: Guidance for Clinical Trial Networks
-
Consumer involvement in clinical trials: ethics committee members and research governance personnel training webinar – an overview
-
Trial safety oversight: Guidance for Clinical Trial Networks
-
Authorship and Publication Policy: Guidance for Clinical Trial Networks
-
Stakeholder Mapping for Clinical Trial Networks
-
Consumers in Clinical Trials: Jenny Lam
-
Consumers in Clinical Trials: Zy Phillips